Fiber Supplement

Benefiber

88 adverse event reports submitted to the FDA · 2004–2023 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 88 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Constipation

Malaise

Diarrhoea

Diverticulitis

Abdominal pain upper

Gastrointestinal disorder

Headache

Drug Dependence

Irritable Bowel Syndrome

Drug ineffective

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Other Serious or Important Medical Event	65
Death	13
Hospitalization	12
Visited a Health Care Provider	8
Other Outcome	4
Visited Emergency Room	4
Life Threatening	2
Disability	1
Other Serious Outcome	1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

50–64

65–79

80+

Unknown

65 reports had age data; 23 unknown.

Gender

Male

Female

Unknown/Not Reported

Reports by Year

Annual report counts from 2004–2023. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'04

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Hover bars for exact counts.

Context about this data: Reports heavily concentrated in 2013 (74% of total). High concentration may reflect a recall, enforcement action, batch filing, or litigation-driven reporting rather than ongoing consumer use.

← View all Benefiber products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology · How to read this data